Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.65
Bid: 32.65
Ask: 33.05
Change: -0.55 (-1.66%)
Spread: 0.40 (1.225%)
Open: 34.00
High: 34.00
Low: 32.50
Prev. Close: 33.20
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update re: securitisation waiver granted

20 Apr 2020 07:00

RNS Number : 1169K
Marston's PLC
20 April 2020
 

20 April 2020

 

MARSTON'S PLC

("Marston's" or "the Group")

 

COVID-19 Update re: securitisation waiver granted

 

Marston's provides the following update in light of the COVID-19 virus.

We continue to take an extremely prudent approach in our management of the business during this period of unprecedented uncertainty, the timescale of which remains unclear pending further guidance from the UK Government as to how, and when, the current state of much reduced social activity can be relaxed and pubs allowed to re-open.

 

In addition to the actions which have been taken to reduce the Group's overall cost base, outlined in our previous update on 18 March, Marston's Issuer PLC has also taken the precautionary measure of securing a waiver of a breach that might arise under the 30 day suspension of business and operations provision under the terms of the Group's secured funding platform. The waiver has been granted until 29 May 2020 with an automatic extension to 15 June 2020 in certain circumstances.

 

The Group is also reviewing whether there is a need to consult with bondholders about further possible covenant waivers under the secured funding platform in light of the impact of the UK Government's measures on the business.

 

 

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners

Ralph Findlay, Chief Executive Officer

Justine Warren Tel: 07785 555692

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood Tel: 07831 379122

 

NOTES TO EDITORS

· Marston's is a leading pub operator and independent brewer.

· It has an estate of around 1,400 pubs situated nationally, comprising managed, franchised and leased pubs.

· It is the UK's leading brewer of premium cask and packaged ales, including Marston's Pedigree, Wainwright, Lancaster Bomber and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers. Marston's has added Bombardier, Courage and McEwan's to its brand portfolio most recently, as well as a range of licensed brands including Young's, Founders and Estrella Damm.

· Marston's employs around 14,000 people.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKCBBKBKBOQD
Date   Source Headline
3rd Jun 20139:49 amRNSTotal Voting Rights
17th May 201311:54 amRNSDirector/PDMR Shareholding
16th May 20134:11 pmRNSDirector/PDMR Shareholding
16th May 20137:00 amRNSInterim Results
16th May 20137:00 amRNSAppointment of Chairman
2nd May 20139:27 amRNSTotal Voting Rights
22nd Apr 20137:00 amRNSProposals to help struggling pubs get a fair deal
17th Apr 20137:00 amRNSSegmental Reporting and Trading Update
2nd Apr 201310:29 amRNSTotal Voting Rights
26th Mar 20132:37 pmRNSDirector/PDMR Shareholding
20th Mar 201310:14 amRNSDirector/PDMR Shareholding
1st Mar 201312:46 pmRNSTotal Voting Rights
1st Feb 201310:54 amRNSTotal Voting Rights
22nd Jan 20137:00 amRNSAGM and Interim Management Statement
10th Jan 20134:55 pmRNSBlocklisting Interim Review
2nd Jan 201310:56 amRNSTotal Voting Rights
19th Dec 201211:19 amRNSAnnual Financial Report
18th Dec 20122:05 pmRNSHolding(s) in Company
17th Dec 20123:12 pmRNSHolding(s) in Company
3rd Dec 20123:21 pmRNSTotal Voting Rights
30th Nov 20122:16 pmRNSDirector/PDMR Shareholding
29th Nov 20127:00 amRNSFinal Results
2nd Nov 20123:50 pmRNSHolding(s) in Company
1st Nov 201211:45 amRNSTotal Voting Rights
19th Oct 201211:46 amRNSDirector/PDMR Shareholding
3rd Oct 20127:00 amRNSYear-End Trading Statement & Director Appointment
1st Oct 201211:58 amRNSTotal Voting Rights
10th Sep 20127:03 amRNSChange to the Board of Directors
3rd Sep 201211:31 amRNSTotal Voting Rights
22nd Aug 20121:29 pmRNSBlock Listing Application
1st Aug 201211:45 amRNSTotal Voting Rights
25th Jul 20127:00 amRNSInterim Management Statement
10th Jul 20128:46 amRNSBlocklisting Interim Review
2nd Jul 201212:18 pmRNSTotal Voting Rights
19th Jun 20127:00 amRNSInterests of Directors
1st Jun 201211:43 amRNSTotal Voting Rights
25th May 20122:14 pmRNSHolding(s) in Company
24th May 20124:16 pmRNSHolding(s) in Company
22nd May 20127:00 amRNSDirector/PDMR Shareholding
17th May 20127:00 amRNSInterim Results
1st May 20122:01 pmRNSTotal Voting Rights
2nd Apr 201211:35 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSAnalyst Visit
15th Mar 20128:12 amRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSTrading Update
1st Mar 20123:35 pmRNSTotal Voting Rights
14th Feb 201212:29 pmRNSHolding(s) in Company
1st Feb 20124:10 pmRNSTotal Voting Rights
1st Feb 20124:00 pmRNSDirector Declaration
27th Jan 20123:48 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.